Fundz

Fundz Deep Dive

Everything you need to win Mohan Purushothaman — in one platform.

Who to reach, what to say, and why now on Mohan Purushothaman — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Mohan Purushothaman — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Progentec Diagnostics Appoints Bernard R. Rubin, Do, Mph (Facr, Facp) As Chief Medical Officer

PRIVATEJun 17, 2024•almost 2 years ago

Position

Chairman

Company

Progentec Diagnostics

Mohan Purushothaman
Oklahoma CityBiotechnologyHealth CareHealth Diagnostics

Description

Progentec Diagnostics announced the appointment of Bernard R Rubin, DO, MPH (FACR, FACP), a seasoned rheumatology and immunology expert, as Chief Medical Officer. Dr Rubin's extensive experience and knowledge in autoimmune diseases and rheumatology will support Progentec in its mission to improve health outcomes for people living with autoimmune diseases.

Company Information

Company

Progentec Diagnostics

Location

Oklahoma City, Oklahoma, United States

About

Progentec Diagnostics is a leader in diagnostic and digital technologies for management of autoimmune diseases, committed to improving access and health outcomes for patients in therapeutic areas with a high level of unmet need.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Progentec Diagnostics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.